- Home
- MRK vs SENEB Comparison
MRK vs SENEB Comparison
Compare MRK & SENEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | SENEB |
|---|---|---|
| Founded | 2000 | 1949 |
| Country | United States | United States |
| Employees | N/A | 6895 |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 880.5M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | SENEB |
|---|---|---|
| Price | $118.67 | $148.03 |
| Analyst Decision | Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $124.38 | N/A |
| AVG Volume (30 Days) | ★ 6.4M | 305.0 |
| Earning Date | 04-30-2026 | 02-05-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.73 | N/A |
| Revenue Next Year | $5.42 | N/A |
| P/E Ratio | $16.58 | ★ $12.93 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $86.92 |
| 52 Week High | $125.14 | $148.03 |
Technical Indicators
Market Signals| Indicator | MRK | SENEB |
|---|---|---|
| Relative Strength Index (RSI) | 52.70 | 78.39 |
| Support Level | $113.27 | $108.68 |
| Resistance Level | $125.14 | N/A |
| Average True Range (ATR) | 2.42 | 0.25 |
| MACD | 0.32 | 1.95 |
| Stochastic Oscillator | 65.68 | 100.00 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About SENEB Seneca Foods Corp. Class B
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.